Key insights into the global Muscle Relaxant Drugs market

During the forecast period 2023-2033, the global muscle relaxant market is expected to reach an estimated value of ~$6 million by 2033 by expanding at a CAGR of ~7%. The market also generated revenue of ~$3 million in 2022. Major key factors driving the global muscle relaxant market growth are the growing number of cases of musculoskeletal disorders across the world as well as the growing geriatric population.

Market definition of muscle relaxants

A wide range of drugs called muscle relaxants are used to relieve or reduce muscle tightness. Some muscle relaxants that work in the brain or spinal cord to stop overexcited nerve pathways are baclofen, methocarbamol, and tizanidine. Other muscle relaxants like dantrolene and botulinum toxin work by acting directly on the muscle. The main disorders used to treat muscle relaxants are spasticity caused by cerebral palsy, multiple sclerosis and stroke. In addition, muscle spasms are typically transient and are associated with conditions such as fibromyalgia, tension headaches, and back problems. The prevalence of this condition is increasing and crucial diagnostic techniques and treatments would drive the market expansion.

For more information on the analysis of this report, see: https://www.researchnester.com/sample-request-486

Global Muscle Relaxant Drugs Market: Growth Drivers

The growth of the global muscle relaxant market is mainly attributed to the increasing number of elderly people worldwide. The main driver driving the expansion of the studied market is the growing elderly population across the world who is more prone to musculoskeletal disorders. In the UK, statistics on work-related MSDs show that 470,000 people would develop new or recurrent MSDs at work in 2021. These circumstances are expected to…